|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, July 26, 2017 ) Pain is one of the main postoperative adverse outcomes causing distress to patients. Degree of postoperative pain experienced by individuals varies. Cause of pain includes peripheral nerve damage during surgery inflammation at the site of the wound and damage to bodily tissues during surgery. Risk factors include site of the operation age level of fear or anxiety surgical procedure personal preference and response to agents given. Treatment for post-operative pain includes analgesia and anesthetics.
Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Post-Operative Pain-Pipeline Review H2 2017 provides comprehensive information on the therapeutics under development for Post-Operative Pain (Central Nervous System) complete with analysis by stage of development drug target mechanism of action (MoA) route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics its complete research and development history and latest news and press releases.
The Post-Operative Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Post-Operative Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes the molecules developed by Companies in Pre-Registration Filing rejected/Withdrawn Phase III Phase II Phase I Preclinical Discovery and Unknown stages are 2 1 10 16 8 14 3 and 2 respectively. Similarly the Universities portfolio in Phase III and Preclinical stages comprises 1 and 1 molecules respectively.
Post-Operative Pain (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases company/university websites clinical trial registries conferences SEC filings investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
For more information about this report at http://www.reportsweb.com/post-operative-pain-pipeline-review-h2-2017
Report Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Post-Operative Pain (Central Nervous System) .
- The pipeline guide reviews pipeline therapeutics for Post-Operative Pain (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise product description descriptive licensing and collaboration details R&D brief MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Post-Operative Pain (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Post-Operative Pain (Central Nervous System) therapeutics based on mechanism of action (MoA) drug target route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Post-Operative Pain (Central Nervous System)
Request a sample copy at http://www.reportsweb.com/inquiry&RW0001881457/sample
Reasons to buy
- Procure strategically important competitor information analysis and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Post-Operative Pain (Central Nervous System) .
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Post-Operative Pain (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Key Company profiles
Abide Therapeutics Inc
AcelRx Pharmaceuticals Inc
Adynxx Inc
AngioChem Inc
Aoxing Pharmaceutical Company Inc
Camurus AB
Cara Therapeutics Inc
Center Laboratories Inc
Colby Pharmaceutical Company
Cytogel Pharma LLC
Dompe Farmaceutici SpA
DURECT Corp
Eupraxia Pharmaceuticals Inc
Ask for Discount at http://www.reportsweb.com/inquiry&RW0001881457/discount
List of Tables
Number of Products under Development for Post-Operative Pain H2 2017
Number of Products under Development by Companies H2 2017
Number of Products under Development by Companies H2 2017 (Contd..1) H2 2017
Number of Products under Development by Companies H2 2017 (Contd..2) H2 2017
Number of Products under Development by Universities/Institutes H2 2017
Products under Development by Companies H2 2017
Products under Development by Companies H2 2017 (Contd..1) H2 2017
Products under Development by Companies H2 2017 (Contd..2) H2 2017
Products under Development by Universities/Institutes H2 2017
Number of Products by Stage and Target H2 2017
Number of Products by Stage and Target H2 2017 (Contd..1) H2 2017
Number of Products by Stage and Mechanism of Action H2 2017
Number of Products by Stage and Mechanism of Action H2 2017 (Contd..1) H2 2017
Number of Products by Stage and Route of Administration H2 2017
Number of Products by Stage and Molecule Type H2 2017
Post-Operative Pain-Pipeline by Abide Therapeutics Inc H2 2017
Post-Operative Pain-Pipeline by AcelRx Pharmaceuticals Inc H2 2017
Post-Operative Pain-Pipeline by Adynxx Inc H2 2017
Post-Operative Pain-Pipeline by AngioChem Inc H2 2017
Post-Operative Pain-Pipeline by Aoxing Pharmaceutical Company Inc H2 2017
Purchase Complete Report at http://www.reportsweb.com/buy&RW0001881457/buy/2000
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
